Cited by 880Sarcoma Diagnosis and TreatmentChromatin Remodeling and CancerAcute Lymphoblastic Leukemia research

The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.

Ewing sarcoma

Grünewald, Thomas G. P., Cidre-Aranaz, Florencia, Surdez, Didier, Tomazou, Eleni M., de Álava, Enrique, Kovar, Heinrich, Sorensen, Poul H., Delattre, Olivier, Dirksen, Uta·2018·Nature Reviews Disease Primers

DOI 10.1038/s41572-018-0003-x

Open this paper in CoChat — free account

Abstract

Ewing sarcoma is the second most frequent bone tumour of childhood and adolescence that can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of 70-80% for patients with standard-risk and localized disease and ~30% for those with metastatic disease. Treatment comprises local surgery, radiotherapy and polychemotherapy, which are associated with acute and chronic adverse effects that may compromise quality of life in survivors. Histologically, Ewing sarcomas are composed of small round cells expressing high levels of CD99. Genetically, they are characterized by balanced chromosomal translocations in which a member of the FET gene family is fused with an ETS transcription factor, with the most common fusion being EWSR1-FLI1 (85% of cases). Ewing sarcoma breakpoint region 1 protein (EWSR1)-Friend leukaemia integration 1 transcription factor (FLI1) is a tumour-specific chimeric transcription factor (EWSR1-FLI1) with neomorphic effects that massively rewires the transcriptome. Additionally, EWSR1-FLI1 reprogrammes the epigenome by inducing de novo enhancers at GGAA microsatellites and by altering the state of gene regulatory elements, creating a unique epigenetic signature. Additional mutations at diagnosis are rare and mainly involve STAG2, TP53 and CDKN2A deletions. Emerging studies on the molecular mechanisms of Ewing sarcoma hold promise for improvements in early detection, disease monitoring, lower treatment-related toxicity, overall survival and quality of life.

Integrity signals

Registry

Crossref · 10.1038/s41572-018-0003-x

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED ARTICLE: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Javaheri, T., Kazemi, Z., Pěnčík, J., Pham, H. T., Kauer, M. O., Noorizadeh, R., Sax, B., Nivarthi, H., Schlederer, M., Maurer, B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.268 · Cited by 18
Self-citation
Retracted
Bone marrow transplant
Szer, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,373
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Self-citation
Targeting EZH2 in cancer
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T. Y., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,160
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 888
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
Kadoch, C., & Crabtree, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500447 · Cited by 877
JHDM2A, a JmjC-Containing H3K9 Demethylase, Facilitates Transcription Activation by Androgen Receptor
Yamane, K., Toumazou, C., Tsukada, Y.-I., Erdjument‐Bromage, H., Tempst, P., Wong, J., & Zhang, Y. (2006) · Cell · doi:10.1016/j.cell.2006.03.027 · Cited by 860

Show all 250 references

Research works printed but not linked: 8

Ewing, J. Diffuse endothelioma of bone. Proc. N. Y. Pathol. Soc. 21, 17 (1921).
Lessnick, S. L., Braun, B. S., Denny, C. T. & May, W. A. Multiple domains mediate transformation by the Ewing’s sarcoma EWS/FLI-1 fusion gene. Oncogene 10, 423–431 (1995).
Ohno, T., Rao, V. N. & Reddy, E. S. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53, 5859–5863 (1993).
Pizzo, P. A. & Poplack, D. G. (eds) Principles and Practice of Pediatric Oncology 7th edn (Lippincott Wililiams & Wilkins, Philadelphia, 2015).
ESMO/European Sarcoma Network Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25 (Suppl 3), iii113–iii123 (2014).
Machado, I., López-Guerrero, J. A., Scotlandi, K., Picci, P. & Llombart-Bosch, A. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing’s sarcoma family of tumors (ESFT). Virchows Arch. Int. J. Pathol. 472, 815–824 (2018).
Wang, Y. X. et al. Inhibiting platelet-derived growth factor beta reduces Ewing’s sarcoma growth and metastasis in a novel orthotopic human xenograft model. In Vivo 23, 903–909 (2009).
Bhan, A. & Mandal, S. S. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim. Biophys. Acta 1856, 151–164 (2015).

Sorted by citations

Items 401–500 of 880

Primary Ewing Sarcoma of the Kidney
Lobo, J., He, H., Ahmed, R., Zein‐Sabatto, B., Winokur, T. S., Wei, S., Harada, S., McKenney, J. K., Myles, J. L., Nguyen, J., et al. (2025) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002427 · Cited by 5
Integrative analysis of T cell-associated markers in Ewing sarcoma reveals prognostic signatures and immune dynamics
Saddozai, U. A. K., Liu, C., Yan, F., Lü, Z., Khawar, M. B., Akbar, M. U., Khattak, S., Sun, H., & Yang, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1586544 · Cited by 5
TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma
Daley, J. D., Mukherjee, E., Ferraro, D., Tufino, A. C., Bailey, N. G., Bhaskar, S., Periyapatna, N., MacFawn, I., Hartwick, S., Kunning, S. R., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0346 · Cited by 6
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
Cruz, F. S. D., Stewart, E. A., Surdez, D., Daley, J. D., Soragni, A., Tomazou, E. M., Alvarez-Perez, J., Feinberg, T. Y., Amatruda, J. F., Ganapathi, S. S., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-25-0428 · Cited by 6
Self-citation
Successful embryo cryopreservation immediately following a full-term delivery in a woman with newly diagnosed Ewing’s sarcoma
Giuliani, E., Ellman, E., Chugh, R. K., & Moravek, M. B. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01445-6 · Cited by 5
Pain in survivors of Ewing sarcoma: Prevalence, associated factors and prediction of recurrence
Heinemann, M., Hoffmann, C., Hardes, J., Guder, W. K., Streitbürger, A., Götte, M., Welz, T. L., Jürgens, H., Ranft, A., Vieth, V., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28801 · Cited by 5
Self-citation
Rationale for Early Detection of EWSR1 Translocation-Associated Sarcoma Biomarkers in Liquid Biopsy
Clanchy, F. I. L. (2021) · Cancers · doi:10.3390/cancers13040824 · Cited by 5
An Efficient Nomogram to Predict Overall Survival of Patients with Pediatric Ewing’s Sarcoma: A Population-Based Study
Dai, K.-N., & Li, A.-B. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s324163 · Cited by 5
Heat‑induced antigen retrieval in fluorescence in situ hybridization: An effective approach enhancing signal intensity in poor‑quality FFPE sections
Yu, Q., Zhang, C., Huang, W., & Li, L. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10915 · Cited by 5
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors
Golinelli, G., Talami, R., Frabetti, S., Candini, O., Grisendi, G., Spano, C., Chiavelli, C., Arnaud, G., Mari, G., & Dominici, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.767253 · Cited by 5
Inhibitors of EYA3 Protein in Ewing Sarcoma
Shah, F. H., & Kim, S. J. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.5.1539 · Cited by 5
Metastatic thoracic and lumbar intramedullary and extramedullary Ewing’s sarcoma: a rare case report and literature review
Mousavi, S. R., Farrokhi, M. R., Eghbal, K., Dehghanian, A., Rezvani, A., & Ghaffarpasand, F. (2022) · Journal of International Medical Research · doi:10.1177/03000605221108095 · Cited by 5
The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population‐based retrospective cohort study
Huang, C. B., Yu, Q., Ding, Z., Zhou, Z., & Shi, X. (2022) · Cancer Medicine · doi:10.1002/cam4.5379 · Cited by 5
Laryngeal extra-skeletal Ewing sarcoma treated with DC-CTL immunotherapy: A case report and review of the literature
Wang, H., Wang, J., Wang, Q., Yang, Y., Guo, J., Ren, C., Mou, Y., Jia, C., & Song, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1003393 · Cited by 5
Bone marrow mesenchymal stem cell-derived exosomal LINC00847 inhibits the proliferation, migration, and invasion of Ewing sarcoma
Huang, L., Xiong, J., Fu, J., Zhou, Z., Yu, H., Xu, J., Wu, L. L., & Cao, K. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202206.015 · Cited by 5
Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing’s sarcoma
Qu, G., Xu, Y., Qu, Y., Qiu, J., Chen, G., Zhao, N., & Deng, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1000949 · Cited by 5
A logical model of Ewing sarcoma cell epithelial‐to‐mesenchymal transition supports the existence of hybrid cellular phenotypes
Silveira, D. A., Gupta, S., Jaeger, M. D. C., de Farias, C. B., Mombach, J. C. M., & Sinigaglia, M. (2023) · FEBS Letters · doi:10.1002/1873-3468.14724 · Cited by 5
Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma
Souza, B. K., Freire, N. H., Monteiro, T. S., Herlinger, A. L., Jaeger, M. D. C., Dalmolin, M., de Farias, C. B., Gregianin, L. J., Brunetto, A. T., Brunetto, A. L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015242 · Cited by 5
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India
Sasi, A., Chitikela, S. D., Ganguly, S., Biswas, B., Pushpam, D., Kumar, A., Khan, S. A., Kumar, V. S., Kale, S. S., Biswas, A., et al. (2024) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2023.2296949 · Cited by 5
CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles
Feo, A. D., Manfredi, M., Mancarella, C., Maqueda, J. J., Giorgis, V. D., Pignochino, Y., Sciandra, M., Cristalli, C., Donadelli, M., & Scotlandi, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031588 · Cited by 5
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling
Dupuy, M., Guéguinou, M., Postec, A., Brion, R., Tesfaye, R. A., Mullard, M., Regnier, L., Amiaud, J., Hubsch, C., Potier‐Cartereau, M., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03199-7 · Cited by 6
Self-citation
Prognosis Implication of a Novel Metabolism-Related Gene Signature in Ewing Sarcoma
Chen, Z., Yang, H., Bu, J., Chen, Q., YANG, Z. K., & Li, H. (2021) · Journal of Oncology · doi:10.1155/2021/3578949 · Cited by 5
A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study
Zheng, Y., Lu, J., Shuai, Z., Wu, Z., & Qian, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-11827-z · Cited by 5
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma
Doğan, İ., İribaş, A., Ahmed, M. A., & Başaran, M. (2022) · Journal of Chemotherapy · doi:10.1080/1120009x.2022.2104295 · Cited by 5
TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment
Brion, R., Gantier, M., Biteau, K., Taurelle, J., Royer, B. B.-L., Verrecchia, F., Rédiní, F., & Guiho, R. (2022) · Cancers · doi:10.3390/cancers14225627 · Cited by 5
SOX6: a double-edged sword for Ewing sarcoma
Marchetto, A., & Grünewald, T. G. P. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1783081 · Cited by 5
Self-citation
Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironmentPreprint
Wrenn, E. D., Apfelbaum, A. A., Rudzinski, E. R., Deng, X., Jiang, W., Sud, S., Noord, R. A. V., Newman, E. A., Garcia, N. M., Hoglund, V. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.12.536619 · Cited by 5
FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapyPreprint
Menon, S., Gracilla, D. E., Breese, M. R., Lin, Y. P., Cruz, F. S. D., Feinberg, T. Y., de Stanchina, E., Galic, A.-F., Allegakoen, H. R., Perati, S. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.30.538578 · Cited by 5
Evaluating Circulating Biomarkers for Diagnosis, Prognosis, and Tumor Monitoring in Pediatric Sarcomas: Recent Advances and Future Directions
Maqueda, J. J., De Feo, A., & Scotlandi, K. (2024) · Biomolecules · doi:10.3390/biom14101306 · Cited by 4
Real-world experiences in patients with Ewing sarcoma treated at a specialist centre in Turkey
Çakmakçı, S., Sarı, N., Akkaş, E. A., Yıldız, F., Karakaya, E., Kaya, B. V., Güngör, B. Ş., Öksüzoğlu, B. Ç., & İlhan, İ. E. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100619 · Cited by 4
Prognostic analysis and clinical characteristics of osteosarcoma and Ewing sarcoma of the rib, sternum, and clavicle: a SEER-based study
He, F., Wang, Z., Chen, G., & Lu, H. (2023) · Journal of International Medical Research · doi:10.1177/03000605231175763 · Cited by 4
Primary Pulmonary Ewing's Sarcoma: A Surprise Diagnosis in a 52-Year-Old Active Smoker
Jamel, E. G., Chiraz, K., & Walha, M. (2023) · Open Respiratory Archives · doi:10.1016/j.opresp.2023.100296 · Cited by 4
Desmoplastic Small Round Cell Tumors of the Gastrointestinal Tract
Gonzalez, J., Ocejo, S., Iribarren, M., Abreu, A. D. C., Bahmad, H. F., & Poppiti, R. (2024) · Cancers · doi:10.3390/cancers16234101 · Cited by 4
KC1036, a multi-kinase inhibitor with anti-angiogenic activity, can effectively suppress the tumor growth of Ewing sarcoma
Ou, X., Gao, G., Ma, Q., Qin, D., Li, K., Feng, M., Gao, Y., Zeng, Y., Chen, Y., He, X., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-10008-6 · Cited by 4
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium
Ribelles, A. J., Felix, A., Benavent, N., Escrivá-Fernández, J., Brahmi, M., Gaspar, N., Gatz, S. A., Grünewald, T. G. P., Linder‐Stragliotto, C., Palmerini, E., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-25-00377 · Cited by 4
Self-citation
Targeting Genome Stability to Mitigate Human Aging and Disease
Toiber, D., & Schumacher, B. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-105942 · Cited by 4
A Systematic Review of the Expression, Signalling and Function of P2 Receptors in Primary Bone Cancer
Tattersall, L., Gagui, D. C., Tippett, V. L., Latif, N. A., Shah, K. M., & Gartland, A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2704122 · Cited by 4
Latest developments in the pathobiology of Ewing sarcoma
Karlina, I., Schroeder, B., Киргизов, К. И., Романцова, О. М., Леонидович, И. А., Nedorubov, A. A., Timashev, P. S., & Ulasov, I. V. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100440 · Cited by 5
Case report: Primary intracranial EWs/PNET in adults: Clinical experience and literature review
Hu, X., Huang, Q., Wang, J., Li, D., Wang, P., & Cai, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1035800 · Cited by 4
Prognostic value of GLCE and infiltrating immune cells in Ewing sarcoma
Wen, J., Yi, L., Wan, L., & Dong, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19357 · Cited by 4
3D ‐Printed Talus‐Calcaneus Prosthesis in Treating Ewing's Sarcoma: A Case Report
Wang, W., An, J., Lu, M., He, X., Li, Z., Wang, Y., Gong, T., Zhou, Y., Min, L., Luo, Y., et al. (2024) · Orthopaedic Surgery · doi:10.1111/os.14279 · Cited by 4
Primary Mediastinal Ewing’s Sarcoma: Post Hoc Analysis from Two International Multicenter Prospective Randomized Trials
Störk, T., Ranft, A., Aigner, C., Jürgens, H., Ladenstein, R. L., Timmermann, B., van den Berg, H., Dirksen, U., & Collaud, S. (2025) · Cancers · doi:10.3390/cancers17010118 · Cited by 4
Self-citation
Results of the Latin American Pediatric Oncology Group (GALOP‐2011) Trial for Patients With Localized Ewing Sarcoma: A Multicentric Study of Interval‐Compressed Multiagent Chemotherapy
Gregianin, L. J., Rosé, A., Milena Villarroel, C., de Almeida, M. T. A., Siqueira, L., Salgado, C., da Costa, G. A., Castillo, L. A., Pestilho, J. F. C. S., Brunetto, A. L., et al. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31554 · Cited by 4
Targeting fusion proteins: a double edge sword?
Tirado, Ò. M. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1628219 · Cited by 4
Ewing Sarcoma-Specific (Re)Expression Models
Knott, M. M. L., & Cidre‐Aranaz, F. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_9 · Cited by 4
Self-citation
Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR
Rodriguez‐Martin, C., & Alonso, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_7 · Cited by 4
A case of an upper anterior abdominal wall extra-skeletal Ewing sarcoma- soft tissue reconstruction with medial intercostal artery perforator flap and free anterolateral thigh fasciocutaneous flap with arteriovenous loop graft
Liu, Y., Subramaniam, S., Sasidaran, R., Ruhana, A. A. H., & Jimeno, Z. K. L. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.103171 · Cited by 4
Ewing sarcoma of the facial soft tissues—a case report
Knight, B., Brierly, G. I., & Dimitroulis, G. (2022) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjac040 · Cited by 4
Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability
Balaraman, K., Deniz, E., Nelson, E., Pilicer, S. L., Atasoy, S., Molotkova, A., Sevim, H., Tiwari, P. B., Üren, A., & Wolf, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115244 · Cited by 4
The Prognostic Value of the Serum Level of C-Reactive Protein for Survival of Children with Ewing’s Sarcoma
Errani, C., Traversari, M., Cosentino, M., Manfrini, M., Basoli, S., Tsukamoto, S., Mavrogenis, A. F., Bordini, B., & Donati, D. M. (2023) · Cancers · doi:10.3390/cancers15051573 · Cited by 4
Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
van Zogchel, L. M. J., Lak, N. S. M., Gelineau, N. U., Sergeeva, I., Stelloo, E., Swennenhuis, J. F., Feitsma, H., van Min, M., Splinter, E., Bleijs, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1124737 · Cited by 4
Large retroperitoneal extraskeletal Ewing’s sarcoma with renal pedicle invasion: a case report
Wu, S., Hsu, C.-K., Yue, C., & Tsai, Y. (2023) · BMC Urology · doi:10.1186/s12894-023-01272-z · Cited by 4
Primary Ewing’s sarcoma of the orofacial region: A narrative review
Indumathi, N., Divya, B., Dineshkumar, T., & Krishnan, R. (2024) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_7_23 · Cited by 4
Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma
Wei, X., Cheng, M., Wang, L., Teng, X., Guo, D., Xin, X., Chen, G., Siyuan, L., & Li, F. (2024) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2024.152321 · Cited by 4
Identifying prognosis and metastasis‑associated genes associated with Ewing sarcoma by weighted gene co‑expression network analysis
Wang, B., Li, J., Li, X., & Ou, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10681 · Cited by 4
FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancerPreprint
Tulpule, A., Menon, S., Breese, M. R., Lin, Y. K., Allegakoen, H. R., Perati, S. R., Heslin, A., Horlbeck, M. A., Weissman, J. S., Sweet-Cordero, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2869150/v1 · Cited by 3
Restricting CAR T Cell Trafficking Expands Targetable Antigen SpacePreprint
Morales, E., Dietze, K. A., Baker, J. M., Wang, A., Avila, S. V., Cardenas, F. I., Radhakrishnan, S. V., Mause, E. R. V., Olson, M., Sun, W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.08.579002 · Cited by 4
Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteinsPreprint
Rask, G. C., Taslim, C., Bayanjargal, A., Cannon, M. V., Selich‐Anderson, J., Crow, J. C., Duncan, A. D., & Theisen, E. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.19.594897 · Cited by 4
Optimizing ATR Inhibition and Cisplatin Synergy in Ewing Sarcoma
Ohmura, S., & Grünewald, T. G. P. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1047 · Cited by 3
Self-citation
Perinatal exposure to ambient fine particle air pollution and risk of childhood ewing sarcoma in a population-based case-control study in California (1988–2015)
Clark, C. J., Wang, R., Wiemels, J. L., Metayer, C., Deziel, N., & Ma, X.-M. (2025) · Environmental Health · doi:10.1186/s12940-025-01159-6 · Cited by 2
Preclinical Pharmacokinetic Evaluation of Mithramycin and Mithramycin SA Tryptophan-Conjugated Analog
Niloy, K. K., Horn, J., Bhuiyan, N. H., Shaaban, K. A., Bhosale, S. S., Prisinzano, T. E., Thorson, J. S., Rohr, J., & Leggas, M. L. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060765 · Cited by 3
Suicide gene therapy targeting ewing sarcoma via an ewing-specific GGAA promoter
Cervera, S. T., Martínez, S., Iranzo-Martínez, M., de Mera, R. M. M.-F., & Alonso, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-14945-6 · Cited by 3
CD99 is a potential diagnostic and immunological biomarker in pan-cancer
Jiang, J., Han, Z., Zhang, H., & Chen, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-03419-w · Cited by 3
Seclidemstat (SP-2577) Induces Transcriptomic Reprogramming and Cytotoxicity in Multiple Fusion–Positive Sarcomas
Rask, G. C., Taslim, C., Bayanjargal, A., Dreher, R. D., Cannon, M. V., Selich‐Anderson, J., Crow, J. C., Duncan, A. D., & Theisen, E. R. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0296 · Cited by 3
PRC2/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma
Downing, N. F., Mills, K. M., & Hollenhorst, P. C. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-25-0389 · Cited by 4
Unraveling Round Cell Sarcomas: A Contemporary Diagnostic Guide Beyond Ewing Sarcoma
Perret, R. E. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100914 · Cited by 3
Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies
Ferraro, E., Macrì, E., Zwergel, C., Lambona, C., Barillari, G., Marchese, C., Locatelli, F., Rota, R., Cassandri, M., & Pomella, S. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104516 · Cited by 3
Prospective evaluation of copy number alterations validates chromosome 1q gain as an independent marker of poor prognosis in localized Ewing sarcoma
Díaz‐Martín, J., Ranft, A., Blanquer-Maceiras, M., Noguera, R., Salguero‐Aranda, C., Delgado‐Bellido, D., Romero‐Pérez, L., Dirksen, U., & de Álava, E. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.105008 · Cited by 3
Self-citation
Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcoma
Richardson, S., Safrastyan, A., Karimpour, M., Gulati, G., Harker, P. J. B., Redfern, A., Pearce, S. P., Makeev, V. J., Brennan, B. M. D., Lee, A. T. J., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00396-7 · Cited by 3
Sarcoma with BCOR gene alterations (BCOR-ITD) of the L3 vertebra in an 8-year-old boy
Sidorov, I. V., Fedorova, A. S., Макарова, Н. П., Konopleva, E. I., Sharlai, A. S., Панферова, А. В., Druy, A. E., & Коновалов, Д. М. (2022) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2022-21-3-84-89 · Cited by 3
Breaking down the tumor immune infiltration within pediatric sarcomas
Weil, R., & Loeb, D. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1187289 · Cited by 4
Limb Salvage Strategy Amendment for a Better Future in the Era of Bone Cancer Therapy: A Cross-Sectional Study in North India
Kumar, B., Sharma, P., Shantanu, K., Kumar, S., Agarwal, R., Kumar, A., & Kumar, D. (2023) · Cureus · doi:10.7759/cureus.41768 · Cited by 3
Animal Models of FUS-Proteinopathy: A Systematic Review
Rezvykh, A. P., Shteinberg, D. A., Bronovitsky, E. V., Ustyugov, A. A., & Funikov, S. Y. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924140037 · Cited by 3
Ewing sarcoma of the pancreas: a pediatric case report and narrative literature review
Liu, Z., Bian, J., Yang, Y., Wei, D., & Qi, S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1368564 · Cited by 3
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma
Aso, A., Aiba, H., Traversari, M., Righi, A., Gambarotti, M., O’Meally, A. A., Σώλου, Κ., Cammelli, S., Bordini, B., Cosentino, M., et al. (2024) · Skeletal Radiology · doi:10.1007/s00256-024-04702-7 · Cited by 3
Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines
López-Carrasco, A., Parra-Haro, K., Vieco-Martí, I., Granados-Aparici, S., Díaz‐Martín, J., Salguero‐Aranda, C., Acevedo-León, D., de Álava, E., Navarro, S., & Noguera, R. (2024) · Cancers · doi:10.3390/cancers16193347 · Cited by 2
First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo
Dernovšek, J., Urbančič, D., Zajec, Ž., Sturtzel, C., Grissenberger, S., Wenninger-Weinzierl, A., Gedgaudas, M., Zubrienė, A., Goričan, T., Grdadolnik, S. G., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107850 · Cited by 3
Revisiting CDKN2A dysregulation in Ewing sarcoma
Paragji, A., Shastri, V. M., Nasri, E., Ligon, J. A., Elliott, L. A., Castillo‐Caro, P., Lamba, J. K., Sayour, E. J., & Seligson, N. D. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70008 · Cited by 3
Gene Fusions as Potential Therapeutic Targets in Soft Tissue Sarcomas
Zheng, Q., Wang, T., Zou, Z., Ma, W., Dong, Z., Zhong, J., Liu, W., Xu, Y., Hu, T., Sun, W. D., et al. (2025) · Biomolecules · doi:10.3390/biom15060904 · Cited by 3
The Spliceosomal Peptidyl Prolyl Isomerase Like 1 Interacts with the Low-Complexity Domain of the RNA Binding Protein EWS Modulating Its Phase Separation Behavior
Parra, G. L., Sohn, E. J., Xu, X., & Libich, D. S. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00193 · Cited by 3
Progress in Nanocarriers‐Based Approaches for the Delivery of Tyrosine Kinase Inhibitors in Bone Cancer: Trends and Prospects
Xu, D., Zhang, W., Pan, Y., Wang, W., Wang, D., & Ding, J. (2025) · IUBMB Life · doi:10.1002/iub.70052 · Cited by 3
Ewing's Sarcoma in a Patient with Crohn's Disease Treated with Ustekinumab: A Case Report
Rao, R. R., Majlessipour, F., Ziring, D., & Baca, N. M. (2020) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2020.0077 · Cited by 3
Construction and validation of nomograms for non‑metastatic Ewing sarcoma: A prognostic factor analysis based on the SEER database
Huang, R., Han, D., Shi, C., Yan, P., Hu, P., Zhu, X., Yin, H., Meng, T., & Huang, Z. (2021) · Oncology Letters · doi:10.3892/ol.2021.13038 · Cited by 3
Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)
Gargallo, P., Bautista, F. J., Ribelles, A. J., Izquierdo, E., Soriano, A., de Rojas, T., Escudero, A., Lavarino, C. E., Solano, P., Hladun, R., et al. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02759-7 · Cited by 3
CyberKnife Stereotactic Radiosurgery for an Unusual Case of Large Brain Metastases From Ewing's Sarcoma in a Pediatric Patient
Mejías, R., Bermúdez-Guzmán, L., & Blanco, A. (2022) · Advances in Radiation Oncology · doi:10.1016/j.adro.2022.100979 · Cited by 3
Targeting epigenetic aberrations of sarcoma in CRISPR era
Tanaka, M., & Nakamura, T. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23142 · Cited by 2
Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications
Dang, D. D., Rosenblum, J. S., Shah, A. H., Zhuang, Z., & Doucet-O’Hare, T. T. (2023) · Cancers · doi:10.3390/cancers15092511 · Cited by 3
In-depth proteome analysis of brain tissue from Ewsr1 knockout mouse by multiplexed isobaric tandem mass tag labeling
Jung, J. W., Kim, H., Park, J., Woo, J. J., Jeon, E., Lee, G., Park, M., Kim, S., Seo, H., Cheon, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42161-7 · Cited by 3
Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma
Liu, Y., Yin, P., Cui, J., Sun, C., Chen, L., Hong, N., & Li, Z. (2023) · BMC Medical Imaging · doi:10.1186/s12880-023-01077-4 · Cited by 3
Roles of USP1 in Ewing sarcoma
Jayabal, P., Ma, X., & Shiio, Y. (2024) · Genes & Cancer · doi:10.18632/genesandcancer.235 · Cited by 3
Ewing Sarcoma Related protein 1 recognizes R‐loops by binding DNA forks
Lay, M. A., Thompson, V. F., Adelakun, A. D., & Schwartz, J. C. (2024) · Biopolymers · doi:10.1002/bip.23576 · Cited by 3
Quest for discovering novel CDK12 inhibitor
Debnath, A., Singh, R. K., Mazumder, R., Mazumder, A., Srivastava, S., Chaudhary, H., Mangal, S., Sanchitra, J., Tyagi, P. K., Singh, S. K., et al. (2024) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2024.2441185 · Cited by 3
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
Babatunde, O. O., Membribes, S. C., Anthonescu, C., Bradić, M., O’Malley, B., Linkov, I., Bartlett, E. K., Momtaz, P., Alektiar, K. M., Gounder, M. M., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00878-w · Cited by 3
Ewing's sarcoma presenting as a cervical intradural extramedullary tumor in a 42 year old: Report of a case
Johnson, M. D., Korones, D. N., L-N, H., Walter, K. A., & Hussain, A. H. (2019) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2019.100634 · Cited by 3
Germline Variation and Somatic Alterations in Ewing Sarcoma
Machiela, M. J., & Grünewald, T. G. P. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_1 · Cited by 3
Self-citation
Systems Biology Analysis for Ewing Sarcoma
Petrizzelli, M., Merlevede, J., & Zinovyev, A. Y. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_23 · Cited by 4
Nomograms to Predict Lung Metastasis Probability and Lung Metastasis Subgroup Survival in Malignant Bone Tumors
Wang, J., Fan, Y., & Xia, L. (2021) · Future Oncology · doi:10.2217/fon-2020-0553 · Cited by 3
What's in a name? Molecular subclassification of sarcomas creates fresh challenges
Díaz‐Martín, J., Biscuola, M., Benoit, J., Marcilla, D., Civantos, G., & de Álava, E. (2018) · The Journal of Pathology · doi:10.1002/path.5206 · Cited by 3
Analysis of Regulatory DNA Sequences by Dual-Luciferase Reporter Assays in Ewing Sarcoma
Hölting, T. L. B., & Knott, M. M. L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_10 · Cited by 3
Molecular Approaches to Diagnosis in Ewing Sarcoma: Targeted RNA Sequencing
Salguero‐Aranda, C., Beltrán-Povea, A., & Díaz‐Martín, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_8 · Cited by 3

Authors: Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U.
Affiliations: German Cancer Research Center (DE)
Inserm (FR)
St. Anna Children's Cancer Research Institute (AT)
University of British Columbia (CA)
Corresponding author: Grünewald, Thomas G. P.
ORCID: Grünewald, Thomas G. P.
Surdez, Didier
Tomazou, Eleni M.
Kovar, Heinrich
Sorensen, Poul H.
Delattre, Olivier
Dirksen, Uta
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2018-07-05
Volume: 4
Issue: 1
Pages: 5-5
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-018-0003-x
OpenAlex: W4211227438
Cited by: 873
References: 250
Citations by year: 2026: 114 · 2025: 155 · 2024: 104 · 2023: 103 · 2022: 158 · 2021: 115 · 2020: 66 · 2019: 49 · 2018: 8
FWCI: 10.61
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Keywords: Ewing sarcoma, EWSR1-FLI1 fusion, CD99, epigenetic reprogramming, STAG2 mutation, TP53 mutation, CDKN2A deletion, treatment toxicity, cancer survivorship, soft tissue sarcoma
MeSH terms: 12E7 Antigen, Humans, Neoplasm Metastasis, Quality of Life, Radiography, Risk Factors, Sarcoma, Ewing, RNA-Binding Protein EWS, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ewing sarcoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks